Autres langues Beta Drugs Limited

Actions

BETA

INE351Y01019

Marché Fermé - NSE India S.E. Autres places de cotation 13:40:47 29/04/2024			Varia. 5j.	Varia. 1 janv.
1 300 ^INR	-0,49%		-7,04%	-11,56%

2023	Beta Drugs Limited annonce ses résultats pour le semestre clos le 30 septembre 2023	CI
2023	Beta Drugs Limited annonce ses résultats pour l'exercice clos le 31 mars 2023	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2023	07/11
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2023	08/05/23
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2022	27/10/22
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2022	27/04/22
Beta Drugs Limited Gets DCGI Approval for Its New Drug KABONIB	12/04/22
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2021	10/11/21
Beta Drugs Ltd Receives WHO- GMP Approval for Its API Plant	19/07/21
Beta Drugs Limited Announces Demise of Vijvay Kumar Batra, Managing Director and Announces Executive Promotions	27/01/21
Beta Drugs Limited Announces Demise of Vijvay Kumar Batra, Board Chairman; Promotes Rahul Batra to the Board Chairman	27/01/21
Beta Drugs Limited Appoints Mr. Varun Batra as Joint Managing Director of the Company	27/01/21
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2020	12/11/20
1,732,000 Equity Shares of Beta Drugs Limited are subject to a Lock-Up Agreement Ending on 15-OCT-2020.	15/10/20
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2020	29/05/20
Beta Drugs Ltd. Receives Registration Certificates for 20 Injectables from Ministry of Health Uzbekistan	27/04/20
Beta Drugs Limited acquired Adley Lab Ltd from group of shareholders for INR 45 million.	25/10/19
Beta Drugs Limited Reports Earnings Results for the Half Year Ended September 30, 2019	23/10/19
Beta Drugs Limited agreed to acquire Adley Lab Ltd from a group of shareholders for INR 45.04 million	30/05/19
Beta Drugs Limited Reports Earnings Results for the Full Year Ended March 31, 2019	13/05/19
4,621,500 Equity Shares of Beta Drugs Limited are subject to a Lock-Up Agreement Ending on 15-OCT-2018.	15/10/18
Beta Drugs Limited has completed an IPO in the amount of INR 195.16 million.	11/10/17

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Beta Drugs Limited

Actions

BETA

INE351Y01019

Autres langues

Filtres